These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30035417)

  • 21. Diagnostic value of nerve growth factor in detrusor overactivity: a study on women with mixed urinary incontinence.
    Salehi-Pourmehr H; Ghojazadeh M; Jahantabi E; Hajebrahimi S
    Int Urol Nephrol; 2021 Aug; 53(8):1557-1562. PubMed ID: 33866484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Urinary Nerve Growth Factor and Brain-Derived Neurotrophic Factor be used in the Diagnosis and Follow-Up of Voiding Dysfunction in Children?
    Özdemir K; Dinçel N; Berdeli A; Mir S
    Urol J; 2016 Jun; 13(3):2690-6. PubMed ID: 27351324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
    Radziszewski P; Crayton R; Zaborski J; Członkowska A; Borkowski A; Bossowska A; Majewski M
    Mult Scler; 2009 Jul; 15(7):860-8. PubMed ID: 19542265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BDNF and NGF gene polymorphisms and urine BDNF-NGF levels in children with primary monosymptomatic nocturnal enuresis.
    Ece A; Coşkun S; Şahin C; Tan I; Karabel D; Çim A
    J Pediatr Urol; 2019 May; 15(3):255.e1-255.e7. PubMed ID: 30981636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia.
    Şekerci ÇA; Işbilen B; Işman F; Akbal C; Şimşek F; Tarcan T
    J Urol; 2014 Jan; 191(1):199-205. PubMed ID: 23973519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
    Khavari R; Karmonik C; Shy M; Fletcher S; Boone T
    J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary neurotrophic peptides in postmenopausal women with and without overactive bladder.
    Pennycuff JF; Schutte SC; Hudson CO; Karp DR; Malykhina AP; Northington GM
    Neurourol Urodyn; 2017 Mar; 36(3):740-744. PubMed ID: 27062604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary nerve growth factor: a biomarker for detrusor overactivity in children? A meta-analysis and trail sequential analysis.
    Deng C; Zhang W; Peng Q; Hu X; Li M; Gao L; Xu J; Su J; Xia X
    Pediatr Surg Int; 2019 Sep; 35(9):1027-1032. PubMed ID: 30729304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
    Liu HT; Lin H; Kuo HC
    Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
    Lemack GE; Frohman EM; Zimmern PE; Hawker K; Ramnarayan P
    Urology; 2006 May; 67(5):960-4. PubMed ID: 16635509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
    Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
    Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.
    Ciszowski K; Gomółka E; Gawlikowski T; Szpak D; Potoczek A; Boba M
    Przegl Lek; 2016; 73(8):552-9. PubMed ID: 29677430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review.
    Rachaneni S; Arya P; Latthe P
    Int Urogynecol J; 2013 Oct; 24(10):1603-9. PubMed ID: 23649686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for a prospective observational study of cortical lower urinary tract control changes following intradetrusor injection of botulinum toxin-A in patients with multiple sclerosis.
    Elizondo RA; Karmonik C; Boone TB; Khavari R
    BMJ Open; 2017 Feb; 7(2):e013225. PubMed ID: 28159850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
    Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
    J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OnabotulinumtoxinA and multiple sclerosis.
    Schurch B; Carda S
    Ann Phys Rehabil Med; 2014 Jul; 57(5):302-314. PubMed ID: 24953702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.